𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-Effectiveness of Thrombolytics: A Simplified Model

✍ Scribed by Rabuş, Şule Apikoğlu ;lzzettin, Fikret Vehbi ;Sancar, Mesut ;Rabuş, Murat Bülent ;Kırma, Cevat ;Yakut, Cevat


Book ID
106494416
Publisher
Springer
Year
2005
Tongue
Dutch
Weight
237 KB
Volume
27
Category
Article
ISSN
1573-739X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A Cost-Effectiveness Model for the Asses
✍ James S. Catterall 📂 Article 📅 1998 🏛 John Wiley and Sons ⚖ 187 KB 👁 1 views

This chapter describes and illustrates techniques used to assess productivity in colleges and universities. A brief discussion of issues surrounding productivity in higher education sets the context. The chapter then turns to definitions of cost analysis and the specific techniques of cost-benefit a

A Bayesian model averaging approach for
✍ Caterina Conigliani; Andrea Tancredi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

## Abstract We consider the problem of assessing new and existing technologies for their cost‐effectiveness in the case where data on both costs and effects are available from a clinical trial, and we address it by means of the cost‐effectiveness acceptability curve. The main difficulty in these an

A model to predict the cost-effectivenes
✍ Afschin Gandjour 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

## Abstract High costs and deficits in the care of patients with chronic diseases have triggered numerous programs to improve the quality and efficiency of treatment of chronic diseases. Decision makers need to estimate the impact of a disease management program (DMP) on long‐term costs and cost‐ef

Bayesian cost-effectiveness analysis wit
✍ Miguel A. Negrín; Francisco J. Vázquez-Polo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d